Home

BRYAN E ROBERTS

CIK 1239242 · last filed 2023-06-16

BRYAN E ROBERTS is a corporate insider who has filed 94 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for TXG, was dated Jun 16, 2023. Across all open-market trades the lifetime net is −$223.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $243.3M across reported positions. 6 SEC filings were submitted jointly with Anders D Hove.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$243.32M

Companies

9

Total Filings

94

Lifetime Open-Market Net

-$223.70M

Filer Profile

Reported Address
C/O VENROCK ASSOCIATES
2494 SAND HILL ROAD STE 200
MENLO PARK, CA 94025
Related Filers
Anders D Hove — 6 joint filings, latest 2014-07-30
NEUROCRINE BIOSCIENCES INC — 2 joint filings, latest 2010-01-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TXG Director 3,878,925 $62.65 $243.01M -$218.40M 13 2023-06-16
CASTLIGHT HEALTH, INC. (CSLT) Delisted Director 0 $2.05 $0 $4.79M 16 2022-02-18
Achaogen, Inc. (AKAO) Delisted Director 637,675 — — $0 6 2018-06-07
Vitae Pharmaceuticals, Inc (VTAE) Delisted Director 275,450 — — $6.18M 4 2016-05-27
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 5,786 — — -$3.05M 11 2015-11-04
IRWD Director 71,951 $4.26 $306.5K -$13.16M 35 2015-06-16
ATHENAHEALTH INC (ATHN) Delisted Director 50 $9.59 $480 -$48.3K 5 2009-05-26
XENOPORT INC (XNPT) Delisted Director 20,279 — — -$2.9K 3 2007-06-01
SIRNA THERAPEUTICS INC (RNAI) Delisted Director 0 — — $0 1 2007-01-03

Recent Filings

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-16 TXG Grant (A) +1,865 $0 EDGAR
2023-05-19 TXG Conv (C) +3,790,422 $0 EDGAR
2022-06-17 TXG Grant (A) +2,120 $0 EDGAR
2022-02-18 CASTLIGHT HEALTH, INC. (CSLT) Delisted Disp (D) −5,660,448 $0 EDGAR
2021-06-15 TXG Grant (A) +625 $0 EDGAR
2021-06-14 CASTLIGHT HEALTH, INC. (CSLT) Delisted Grant (A) +70,707 $0 EDGAR
2021-05-04 TXG Conv (C) +2,000,000 $0 EDGAR
2020-12-10 TXG Mixed +2,093,487 $0 EDGAR
2020-09-18 TXG Other (J) −1,128,196 $0 EDGAR
2020-06-17 TXG Grant (A) — $0 EDGAR
Showing 1–10 of 94
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.